|
|
|
Insider
Information: |
Robinson James A. Jr. |
Relationship: |
Director |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
4,412 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$105,491 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,412 |
|
|
Total
Value |
$105,491 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alkermes Plc |
ALKS |
President & COO,Alkerm... |
2019-04-04 |
4,412 |
2019-04-04 |
0 |
Premium* |
|
Urovant Sciences Ltd. |
UROV |
PEO;CEO/Urovant Scienc... |
2021-03-29 |
0 |
2020-01-10 |
0 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
Director |
2021-03-19 |
0 |
2020-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALKS |
Alkermes Plc |
President & COO,Alkermes, Inc. |
|
2019-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
Director |
|
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,480 |
12,480 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Director |
|
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
23,453 |
23,453 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Director |
|
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,453) |
0 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
PEO;CEO/Urovant Sciences, Inc. |
|
2021-03-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,385) |
0 |
0 |
- |
|
ALKS |
Alkermes Plc |
President & COO,Alkermes, Inc. |
|
2019-04-04 |
4 |
D |
$35.89 |
$65,966 |
D/D |
(1,838) |
4,412 |
0 |
- |
|
UROV |
Urovant Sciences Ltd. |
PEO; CEO/Urovant Sciences, Inc |
|
2021-01-10 |
4 |
D |
$16.11 |
$65,970 |
D/D |
(4,095) |
8,385 |
0 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|